These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37713854)

  • 1. Clinical manifestations and risk factors of coronary artery lesions in children with Kawasaki disease.
    Wang L; Zeng X; Chen B
    Medicine (Baltimore); 2023 Sep; 102(37):e34939. PubMed ID: 37713854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective analysis of clinical characteristics and related influencing factors of Kawasaki disease.
    Cai WJ; Ding SG
    Medicine (Baltimore); 2022 Dec; 101(52):e32430. PubMed ID: 36596080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for coronary artery lesions in children with Kawasaki disease.
    Duan J; Jiang H; Lu M
    Arch Argent Pediatr; 2020 Oct; 118(5):327-331. PubMed ID: 32924395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
    Huiling L; Yaping L; Xiufen H
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two cases of Kawasaki disease: Clinical characteristics and onset of fever and gastrointestinal symptoms.
    Liu HQ; Shi XY; Jia PS; Huo YF; Mu MM; Xie L; Wang HL
    Immun Inflamm Dis; 2023 Jul; 11(7):e929. PubMed ID: 37506133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affects of "age at diagnosis" on coronary artery lesions in patients with incomplete kawasaki disease.
    Cho MA; Choi YJ; Jung JW
    Korean Circ J; 2010 Jun; 40(6):283-7. PubMed ID: 20589201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Risk Factors for Coronary Artery Lesion in Children with Kawasaki Disease.
    Bai B; Ya JL; Yan C
    J Coll Physicians Surg Pak; 2022 Aug; 32(8):1037-1041. PubMed ID: 35932129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical analysis of 942 cases of Kawasaki disease].
    Zhang W; Li Q; Zhao XD; Tang XM; Wang XG; Wang M; Wu DQ; Ou Q; Yang XQ
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):324-8. PubMed ID: 16780705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of PCT, BNP and Inflammatory Factors in Children with Kawasaki Disease and Their Correlation with Coronary Artery Lesions.
    Feng H; Chai H; Li D; Shi C; Xu Y; Liu Y
    Altern Ther Health Med; 2024 Jan; 30(1):302-306. PubMed ID: 37820655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment change and coronary artery abnormality in incomplete Kawasaki disease.
    Nomura Y; Yashiro M; Masuda K; Nakamura Y
    Pediatr Int; 2020 Jul; 62(7):779-784. PubMed ID: 32219919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factors for coronary artery lesions secondary to Kawasaki disease in children].
    Deng YC; Wang X; Tang XC; Huang CZ; Yang J; Mo LY
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Sep; 17(9):927-31. PubMed ID: 26412172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Predictive indicators and risk model construction for coronary artery lesions in Kawasaki disease children over 5 years old].
    Zhang H; Zhang Y
    Zhongguo Dang Dai Er Ke Za Zhi; 2024 May; 26(5):461-468. PubMed ID: 38802905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of coronary artery lesions in indolent Kawasaki disease following initial spontaneous defervescence: a retrospective cohort study.
    Takahashi T; Sakakibara H; Morikawa Y; Miura M
    Pediatr Rheumatol Online J; 2015 Nov; 13(1):44. PubMed ID: 26530040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk factors for coronary artery lesions in children with Kawasaki disease].
    Li Y; Wang XM; Liu YL; Shi K; Yang YF; Guo YH
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Dec; 14(12):938-41. PubMed ID: 23234782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
    Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
    Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kawasaki disease in neonates: a case report and literature review.
    Shen M; Liu D; Ye F; Zhang J; Wang J
    Pediatr Rheumatol Online J; 2024 Jan; 22(1):23. PubMed ID: 38287358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin for the treatment of Kawasaki disease.
    Broderick C; Kobayashi S; Suto M; Ito S; Kobayashi T
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014884. PubMed ID: 36695415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Risk of Recrudescent Fever in Children With Kawasaki Disease Treated With Intravenous Immunoglobulin and Low-Dose vs High-Dose Aspirin.
    Platt B; Belarski E; Manaloor J; Ofner S; Carroll AE; John CC; Wood JB
    JAMA Netw Open; 2020 Jan; 3(1):e1918565. PubMed ID: 31899532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte Hydrogen Sulfide Production Predicts Coronary Artery Lesions in Children with Kawasaki Disease: A Preliminary, Single-Center Study.
    Lin J; Zhao H; Jiao F; Ma L; Wang W; Ma L
    J Trop Pediatr; 2020 Apr; 66(2):171-177. PubMed ID: 31302704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting the duration of coronary artery lesions in patients with the Kawasaki disease: a retrospective cohort study.
    Zhang X; He Y; Shao Y; Hang B; Xu Z; Chu M
    Pediatr Rheumatol Online J; 2021 Jun; 19(1):96. PubMed ID: 34174872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.